Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Goodbody Health Inc (GDBY.CN)

Goodbody Health Inc (GDBY.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,299
  • Shares Outstanding, K 364,962
  • Annual Sales, $ 17,058 K
  • Annual Income, $ -2,314 K
  • 60-Month Beta 2.01
  • Price/Sales 0.22
  • Price/Cash Flow 1.96
  • Price/Book 0.65
Trade GDBY.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings 0.00 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.015 +33.33%
on 06/21/22
0.040 -50.00%
on 06/08/22
-0.020 (-50.00%)
since 05/30/22
3-Month
0.015 +33.33%
on 06/21/22
0.060 -66.67%
on 04/05/22
-0.030 (-60.00%)
since 03/30/22
52-Week
0.015 +33.33%
on 06/21/22
0.115 -82.61%
on 08/12/21
-0.065 (-76.47%)
since 06/30/21

Most Recent Stories

More News
Goodbody Health launches Genetic Risk Testing for Cancer and Cardiovascular Diseases

VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it is launching new genetic cancer tests to help...

GDBY.CN : 0.020 (-20.00%)
GDBYF : 0.0192 (+26.32%)
Goodbody Health Granted Care Quality Commission Registration

VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that following its application for registration with...

GDBY.CN : 0.020 (-20.00%)
GDBYF : 0.0192 (+26.32%)
AGM, Plan to De-List from the CSE, Redomicile to Guernsey, And Appointment of Peterhouse as Corporate Adviser

Aligns With Company's Substantial U.K. Presence and Supports Its Growth Strategy

GDBYF : 0.0192 (+26.32%)
GDBY.CN : 0.020 (-20.00%)
Goodbody Health Announces the Launch of Its Core Health Diagnostic Check

VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, it has launched its core UK Health check which...

GDBY.CN : 0.020 (-20.00%)
GDBYF : 0.0192 (+26.32%)
Goodbody Health Inc. Publishes Highest Quarterly Profit to Date in Q1 2022

VANCOUVER, BC / ACCESSWIRE / May 25, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce its highest comprehensive profit of £0.10m and adjusted...

GDBY.CN : 0.020 (-20.00%)
GDBYF : 0.0192 (+26.32%)
Goodbody Health Inc. Publishes 2021 Audited Financial Statements

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

GDBY.CN : 0.020 (-20.00%)
GDBYF : 0.0192 (+26.32%)
Stocks in play: Goodbody Health Inc

Announced that its subsidiary, PhytoVista Laboratories, has been granted a controlled drugs licence ...

GDBY.CN : 0.020 (-20.00%)
Goodbody Health Subsidiary Granted UK Home Office Controlled Drugs Licence

VANCOUVER, BC / ACCESSWIRE / April 11, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that its subsidiary, PhytoVista Laboratories, has...

GDBY.CN : 0.020 (-20.00%)
GDBYF : 0.0192 (+26.32%)
Stocks in play: Goodbody Health Inc

Announces that following the UK Food Standard Agencies publication of the Novel Foods approved list ...

GDBY.CN : 0.020 (-20.00%)
Goodbody Health Products Included on FSA Novel Foods Register

VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, following the UK Food Standard Agencies (FSA)...

GDBY.CN : 0.020 (-20.00%)
GDBYF : 0.0192 (+26.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.037
2nd Resistance Point 0.033
1st Resistance Point 0.027
Last Price 0.020
1st Support Level 0.017
2nd Support Level 0.013
3rd Support Level 0.007

See More

52-Week High 0.115
Fibonacci 61.8% 0.077
Fibonacci 50% 0.065
Fibonacci 38.2% 0.053
Last Price 0.020
52-Week Low 0.015

See More

Business Summary

Goodbody Health Inc is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar